Latest Stock Buy or Sell? Make More Informed Decisions!

Today, Mohsin Bashir commented about whether V-N, NAL-T, TRI-T, JNJ-N, TD-T, BDX-N, IPSU-Q, HSE-T, IMO-T, EK-N, DRYS-Q, AFN-T, UTX-N, MFC-T are stocks to buy or sell.

COMMENT
Markets. There is a big spread between bond yields and equity (earnings) yields so he is currently investing in equities.
DON'T BUY
Good numbers in Q2, which they badly needed. Normally they do a readjustment to their actuarial assumptions in Q3 and that could be a one-time charge that will be material for them. He would watch for what that is before he would be comfortable with this as a long-term hold.
COMMENT
One of the best elevators and escalators manufacturers. Recently won a contract making Pratt & Whitney engine for the A3 narrow body commercial jet. This makes them a candidate for long-term growth. Very cheap.
COMMENT
Manufacture farm equipment. Q2 results beat expectations. A lot of this was a result of sequential improvements in margins. Also have some new exposure to emerging markets. Trades at a discount to its peers.
COMMENT
Has a 50-50 split between the dry bulk industry and oil transportation. Have a younger drilling fleet for ultra deep water drilling. Company is very highly levered. Have $2 billion worth of vessels that they need to pay for.
DON'T BUY
To continue to survive, they would have to sell their intellectual property assets. Would prefer Eastman Chemical (EMN-N), the spin-off.
BUY
Imperial Oil (IMO-T) or Husky (HSE-T)? The size, breadth and its ability of Imperial Oil to maintain and grow its market share would be a positive for him. Husky will have more volatility. This would be a good entry level.
DON'T BUY
Imperial Oil (IMO-T) or Husky (HSE-T)? The size, breadth and its ability of Imperial Oil to maintain and grow its market share would be a positive for him. Husky will have more volatility.
DON'T BUY
The correction in the price is a result of bad earnings at a bad time. Taste the number of challenges. Recently one of its facilities had an explosion and resulted in supply inefficiencies. Also has a lot of competition. Big debt level and they are burning cash quarter over quarter.
TOP PICK
Medical technology. 38 years of consecutive dividend increases. Conservative payout ratio of 28%. 3 segments, medical, diagnostics and biosciences. All 3 have been growing at about 4%-5%. Met or exceeded earnings expectations for the last 5 years, usually 5%.
TOP PICK
One of the best in class. Revenues stream is split about 88% personal/commercial and 12% wholesale. Likes their US operations. Very safe.
TOP PICK
Capable of withstanding a number of different issues, which it has. 8.5% earnings yield and 3.6% dividend yield.
PAST TOP PICK
(A Top Pick June 16/11. Down 13.68%.)
PAST TOP PICK
(A Top Pick June 16/11. Down 6.88%.)
PAST TOP PICK
(A Top Pick June 16/11. Up 13.47%.)